Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-03-19 Option Award | 2026-03-23 4:30 pm | N/A 2036-03-18 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 72,804 | $0 | 180,195 (Direct) | View |
| 2026-03-03 Tax Withholding | 2026-03-05 6:20 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 11,313 | $20.99 | 107,391 (Direct) | View |
| 2025-07-01 Tax Withholding | 2025-08-20 5:00 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 4,470 | $6.8366 | 118,704 (Direct) | View |
| 2025-07-01 Option Award | 2025-07-03 5:15 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 24,459 | $0 | 123,174 (Direct) | View |
| 2025-03-01 Tax Withholding | 2025-07-03 5:15 pm | N/A N/A | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 1,824 | $7.9166 | 123,174 (Direct) | View |
| 2025-03-15 Option Award | 2025-03-18 8:45 pm | N/A 2035-03-15 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 218,850 | $0 | 255,579 (Direct) | View |
| 2024-03-15 Option Award(A) | 2024-03-20 7:39 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 91,494 | $0 | 91,494 (Direct) | View |
| 2024-03-15 Option Award | 2024-03-19 4:48 pm | N/A 2034-03-14 | Structure Therapeutics Inc. | GPCR | Ma Yingli CHIEF TECHNOLOGY OFFICER | 128,223 | $0 | 128,223 (Direct) | View |
Ownership | 2023-02-02 6:21 pm | N/A 2032-01-19 | Structure Therapeutics Inc. | GPCR | Ma Yingli Chief Technology Officer | 0 | $0 | 400,000 (Direct) | View |